カルボキシセラピーの市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

カルボキシセラピーの世界市場は、2024年には3,531万米ドルと評価され、2030年には6,994万米ドルに達すると予測され、予測期間中のCAGRは12.04%で拡大すると予測されています。

同市場は、最小限の回復時間で目に見える結果を提供する非侵襲的な美容施術に対する消費者の嗜好の高まりによって、着実に成長しています。カルボキシセラピーの-二酸化炭素の制御された注入によって投与され、セルライト、ストレッチマーク、目の下のクマ、局所的な脂肪沈着などの症状に対する有効性で人気を集めています。皮膚の弾力性を改善し、コラーゲン産生を刺激し、微小循環を促進するその能力は、美容と医療の分野でその魅力を高めています。

自然な仕上がりを求める消費者のニーズと美容意識の高まり、可処分所得の増加が市場拡大に拍車をかけています。ソーシャルメディアや有名人の動向を通じて広まる美の理想像の影響は、特に若年層に影響を及ぼしています。安全性、精度、快適性の向上を可能にする機器設計の技術開発は、より広範な臨床採用を促しています。さらに、カルボキシセラピーのは、マイクロニードル、メソセラピー、レーザー治療と並んで、総合的な美容治療にますます組み込まれるようになっています。また、創傷治癒や脱毛症などの医学的適応症にも応用が広がっており、皮膚科や治療現場での関連性が拡大しています。

主要市場促進要因

非侵襲的美容処置に対する需要の高まり

主な市場課題

限られた認知度と規制上の制約

主要市場動向

携帯型および家庭用デバイスの採用増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のカルボキシセラピー市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（卓上、ポータブル、その他）
  • 用途別（美容医療、皮膚科、婦人科、血管科、整形外科・リウマチ科、スポーツ医学、その他）
  • エンドユーザー別（病院、美容クリニック、ウェルネスセンター）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米のカルボキシセラピー市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のカルボキシセラピー市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のカルボキシセラピー市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のカルボキシセラピー市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのカルボキシセラピー市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• DTA Medical
• Fosun Pharmaceutical Co., Ltd.
• Merz Pharma GmbH & Co. KGaA
• Cosmo Pro Ltd.
• Allergan plc
• Carbossiterapia Italiana
• Beijing Jontelaser Technologies Co. Ltd.
• Kastner-Praxisbedarf
• Mezopharma
• Alvi Prague

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Carboxy Therapy Market was valued at USD 35.31 Million in 2024 and is projected to reach USD 69.94 Million by 2030, expanding at a CAGR of 12.04% during the forecast period. The market is growing steadily, driven by rising consumer preference for non-invasive cosmetic procedures that offer visible results with minimal recovery time. Carboxy therapy-administered through the controlled infusion of carbon dioxide-has gained traction for its efficacy in treating conditions such as cellulite, stretch marks, under-eye circles, and localized fat deposits. Its ability to improve skin elasticity, stimulate collagen production, and enhance microcirculation has increased its appeal across aesthetic and medical segments.

Consumer demand for natural-looking results, along with increased aesthetic awareness and disposable income, is fueling market expansion. The influence of beauty ideals promoted via social media and celebrity trends is particularly impacting younger demographics. Technological developments in device design-enabling enhanced safety, precision, and comfort-are encouraging broader clinical adoption. Furthermore, carboxy therapy is being increasingly incorporated into comprehensive aesthetic treatments alongside microneedling, mesotherapy, and laser therapies. Its application is also widening to include medical indications such as wound healing and alopecia, which is expanding its relevance in dermatological and therapeutic care settings.

Key Market Drivers

Rising Demand for Non-Invasive Aesthetic Procedures

The growing preference for minimally invasive cosmetic treatments is a key factor propelling the carboxy therapy market. As patients seek procedures with fewer risks, faster recovery, and natural outcomes, carboxy therapy aligns with these expectations by offering aesthetic enhancements without surgical intervention. The technique is especially effective for facial rejuvenation, body contouring, and skin tightening. According to the American Society of Plastic Surgeons, minimally invasive procedures increased by 7% in 2023, outpacing surgical ones. With rising demand for treatments such as neuromodulators, dermal fillers, and chemical peels, carboxy therapy is gaining attention as a complementary or alternative solution.

Key Market Challenges

Limited Awareness and Regulatory Constraints

One of the main challenges facing the market is the lack of widespread awareness among patients and healthcare providers in certain regions, especially in developing countries where aesthetic medicine is still evolving. Additionally, inconsistent regulations regarding device usage and practitioner certification can lead to varied treatment outcomes and patient safety concerns. The absence of standardization, along with potential side effects like bruising and discomfort, may deter first-time users. Furthermore, high equipment costs and ongoing consumable expenses create financial barriers for smaller clinics, limiting broader market adoption.

Key Market Trends

Rising Adoption of Portable and Home-Use Devices

The growing popularity of portable and home-use carboxy therapy devices is a notable market trend. Consumers are increasingly seeking convenience-driven skincare solutions that offer flexibility and privacy. Compact, easy-to-use devices equipped with pre-set treatment modes and digital CO2 control features are enabling at-home treatments, particularly among younger, tech-savvy users. These portable systems are reshaping the way individuals manage beauty regimens, offering cost-effective alternatives to clinic visits while still delivering noticeable results. This trend is expanding the reach of carboxy therapy beyond professional settings into the consumer wellness market.

Key Market Players

• DTA Medical
• Fosun Pharmaceutical Co., Ltd.
• Merz Pharma GmbH & Co. KGaA
• Cosmo Pro Ltd.
• Allergan plc
• Carbossiterapia Italiana
• Beijing Jontelaser Technologies Co. Ltd.
• Kastner-Praxisbedarf
• Mezopharma
• Alvi Prague

Report Scope:

In this report, the Global Carboxy Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Carboxy Therapy Market, By Type:

• Tabletop
• Portable
• Others

Carboxy Therapy Market, By Application:

• Aesthetic Medicine
• Dermatology
• Gynaecology
• Angiology
• Orthopaedic & Rheumatology
• Sports Medicine
• Others

Carboxy Therapy Market, By End User:

• Hospitals
• Aesthetic Clinics
• Wellness Centers

Carboxy Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Carboxy Therapy Market.

Available Customizations:

Global Carboxy Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Carboxy Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Tabletop, Portable, Others)
  • 5.2.2. By Application (Aesthetic Medicine, Dermatology, Gynaecology, Angiology, Orthopaedic & Rheumatology, Sports Medicine, Others)
  • 5.2.3. By End User (Hospitals, Aesthetic Clinics, Wellness Centers)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Carboxy Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Carboxy Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Carboxy Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Carboxy Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Carboxy Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Carboxy Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Carboxy Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Carboxy Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Carboxy Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Carboxy Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Carboxy Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Carboxy Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Carboxy Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Carboxy Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Carboxy Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Carboxy Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Carboxy Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Carboxy Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Carboxy Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Carboxy Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Carboxy Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Carboxy Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Carboxy Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Carboxy Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. DTA Medical
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Fosun Pharmaceutical Co., Ltd.
• 14.3. Merz Pharma GmbH & Co. KGaA
• 14.4. Cosmo Pro Ltd.
• 14.5. Allergan plc
• 14.6. Carbossiterapia Italiana
• 14.7. Beijing Jontelaser Technologies Co. Ltd.
• 14.8. Kastner-Praxisbedarf
• 14.9. Mezopharma
• 14.10. Alvi Prague

15. Strategic Recommendations

16. About Us & Disclaimer